H. Liehr

发表

RES Function in Experimental and Human Liver Disease

H. Liehr, 1985 .

Hepatic blood flow in rats with galactosamine hepatitis.

H. Liehr, M. Grün, H. Thiel, 1972, Acta hepato-gastroenterologica.

Galactosamine- "hepatitis" in rats with different phagocytic activity of liver RES.

U. Rasenack, H. Liehr, M. Grün, 1975, Acta hepato-gastroenterologica.

Influence of liver-RES on toxic liver damage due to galactosamine.

Heinrich Brunswig, U. Rasenack, H. Liehr, 1974, Acta hepato-gastroenterologica.

Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis.

H. Prytz, J. Holst-Christensen, B. Korner, 1976, Scandinavian journal of gastroenterology.

Histological investigations of intravascular coagulation in rats with gradual occlusion of the portal vein.

H. Liehr, M. Grün, H. Thiel, 1973, Beitrage zur Pathologie.

Endotoxins in liver disease.

H. Liehr, M. Grün, 1979, Progress in liver diseases.

ENDOTOXÆMIA IN LIVER CIRRHOSIS : TREATMENT WITH POLYMYXIN B

Heinrich Brunswig, H. Liehr, M. Grün, 1975, The Lancet.

On the pathogenesis of galactosamine hepatitis

W. Reutter, H. Seelig, W. Heine, 1978, Virchows Archiv B Cell Pathology.

Significance of endotoxaemia in experimental "galactosamine-hepatitis" in the rat.

U. Rasenack, H. Liehr, M. Grün, 1977, Acta hepato-gastroenterologica.

A German drug-monitoring study in general practice patients receiving cisapride for functional dyspepsia.

R. Schmidt, H. Liehr, 1993, Scandinavian journal of gastroenterology. Supplement.

Treatment of posttransplant lymphoproliferative disorder with the anti-CD20 monoclonal antibody rituximab alone in an adult after liver transplantation: a new drug in therapy of patients with posttransplant lymphoproliferative disorder after solid organ transplantation?

H. Riess, W. Bechstein, I. Anagnostopoulos, 2000, Transplantation.

Letter: Endotoxaemia in liver cirrhosis: treatment with polymyxin B.

Heinrich Brunswig, H. Liehr, M. Grün, 1975, Lancet.

Endotoxemia in cirrhosis.

H. Liehr, 1981, Gastroenterology.

Endotoxins and Alcoholic Hepatitis

H. Liehr, 1983 .

Lactulose--a drug with antiendotoxin effect.

U. Rasenack, H. Liehr, G. Englisch, 1980, Hepato-gastroenterology.

Endotoxin-induced liver necrosis and intravascular coagulation in rats enhanced by portacaval collateral circulation.

Heinrich Brunswig, U. Rasenack, H. Liehr, 1975, Gut.

Endotoxins and the pathogenesis of hepatic and gastrointestinal diseases.

H. Liehr, 1982, Ergebnisse der inneren Medizin und Kinderheilkunde.

The Limulus assay for endotoxemia, as applied in gastroenterology.

H. Liehr, 1979, Progress in clinical and biological research.

[Consumption coagulopathy in toxic liver lesions due to Amanita phalloides poisoning].

Heinrich Brunswig, E. Richter, H. Liehr, 1972, Deutsche Medizinische Wochenschrift.

Virus-binding activity of fibronectin: masking of hepatitis A virus.

R. Waldherr, H. Seelig, G. Pott, 1984, Journal of virological methods.

[Endotoxinemia in acute pancreatitis (author's transl)].

H. Seelig, H. Liehr, M. Grün, 1980, Leber, Magen, Darm.

Regulation of Fibrinogen Synthesis in Portal Hypertension

Heinrich Brunswig, H. Liehr, M. Grün, 1974, Thrombosis and Haemostasis.

Hepatic clearance of endotoxins: differences in arterial and portal venous infusion.

H. Liehr, M. Grün, J. Wolter, 1978, Journal of the Reticuloendothelial Society.

[Late damage from thorotrast].

H. Liehr, G. Beneke, N. Heger, 1969, Die Medizinische Welt.

[Nonalcoholic fatty liver hepatitis and fatty cirrhosis mimicking alcoholic liver diseases].

H. Liehr, H. Mitschke, H. Spech, 1983, Zeitschrift fur Gastroenterologie.

[Peliosis hepatis. A clinical status inventory].

H. Liehr, H. Spech, 1982, Zeitschrift fur Gastroenterologie.

[Etiology, complications and prognosis of liver cirrhosis in 917 patients. II. Causes of death and prognosis in liver cirrhosis].

H. Kühn, A. Epple, H. Liehr, 1979, Lebensversicherungs Medizin.

Treatment of endotoxemia in galactosamine hepatitis by lactulose administered intravenously.

W. Heine, H. Liehr, 1981, Hepato-gastroenterology.

[Rapid development of liver cirrhosis following acute non-A, non-B hepatitis].

H. Liehr, H. Spech, M. Huth, 1989, Zeitschrift fur Gastroenterologie.

Detection of a non-A, non-B hepatitis associated substance in stools.

H. Seelig, H. Liehr, R. Seelig, 1983, Developments in biological standardization.

Combination therapy with interferon-alpha 2b and ribavirin for the treatment of relapse patients and non-responders with chronic HCV infection.

J. Wechsler, W. Stremmel, T. Goeser, 2001, Zeitschrift fur Gastroenterologie.

Biological consequences of porta-caval collateral circulation. Significance of pancreatic venous blood.

H. Liehr, M. Grün, 1978, Acta hepato-gastroenterologica.

Synergistic action of hepatocyte membrane defect and activated complement system in liver cell death--an experimental approach to fulminant hepatic failure.

H. Seelig, U. Rasenack, H. Liehr, 1978, Acta hepato-gastroenterologica.